These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 26755707)
21. Erythropoietic regulators of iron metabolism. Ganz T Free Radic Biol Med; 2019 Mar; 133():69-74. PubMed ID: 29981834 [TBL] [Abstract][Full Text] [Related]
22. Low hepcidin accounts for the proinflammatory status associated with iron deficiency. Pagani A; Nai A; Corna G; Bosurgi L; Rovere-Querini P; Camaschella C; Silvestri L Blood; 2011 Jul; 118(3):736-46. PubMed ID: 21628413 [TBL] [Abstract][Full Text] [Related]
23. Inflammation regulates TMPRSS6 expression via STAT5. Meynard D; Sun CC; Wu Q; Chen W; Chen S; Nelson CN; Waters MJ; Babitt JL; Lin HY PLoS One; 2013; 8(12):e82127. PubMed ID: 24376517 [TBL] [Abstract][Full Text] [Related]
24. Chronic intermittent hypobaric hypoxia improves iron metabolism disorders via the IL-6/JAK2/STAT3 and Epo/STAT5/ERFE signaling pathways in metabolic syndrome rats. Cui F; Sun J; Mi H; Li B; Tang L; Wang R; Du Y; Guo B; Li Y; Shi M J Trace Elem Med Biol; 2023 Sep; 79():127259. PubMed ID: 37413927 [TBL] [Abstract][Full Text] [Related]
25. Hepcidin-mediated hypoferremic response to acute inflammation requires a threshold of Bmp6/Hjv/Smad signaling. Fillebeen C; Wilkinson N; Charlebois E; Katsarou A; Wagner J; Pantopoulos K Blood; 2018 Oct; 132(17):1829-1841. PubMed ID: 30213871 [TBL] [Abstract][Full Text] [Related]
26. EPO-dependent induction of erythroferrone drives hepcidin suppression and systematic iron absorption under phenylhydrazine-induced hemolytic anemia. Jiang X; Gao M; Chen Y; Liu J; Qi S; Ma J; Zhang Z; Xu Y Blood Cells Mol Dis; 2016 May; 58():45-51. PubMed ID: 27067488 [TBL] [Abstract][Full Text] [Related]
27. Severe microcytic anemia but increased erythropoiesis in mice lacking Hfe or Tfr2 and Tmprss6. Lee P; Hsu MH; Welser-Alves J; Peng H Blood Cells Mol Dis; 2012 Mar; 48(3):173-8. PubMed ID: 22244935 [TBL] [Abstract][Full Text] [Related]
28. Effect of erythropoietin administration on proteins participating in iron homeostasis in Tmprss6-mutated mask mice. Frýdlová J; Rychtarčíková Z; Gurieva I; Vokurka M; Truksa J; Krijt J PLoS One; 2017; 12(10):e0186844. PubMed ID: 29073189 [TBL] [Abstract][Full Text] [Related]
29. Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: new link between hypoxia signaling and iron homeostasis. Lakhal S; Schödel J; Townsend AR; Pugh CW; Ratcliffe PJ; Mole DR J Biol Chem; 2011 Feb; 286(6):4090-7. PubMed ID: 20966077 [TBL] [Abstract][Full Text] [Related]
30. Characterization of erythroferrone structural domains relevant to its iron-regulatory function. Srole DN; Jung G; Waring AJ; Nemeth E; Ganz T J Biol Chem; 2023 Dec; 299(12):105374. PubMed ID: 37866631 [TBL] [Abstract][Full Text] [Related]
31. TMPRSS6 rs855791 modulates hepcidin transcription in vitro and serum hepcidin levels in normal individuals. Nai A; Pagani A; Silvestri L; Campostrini N; Corbella M; Girelli D; Traglia M; Toniolo D; Camaschella C Blood; 2011 Oct; 118(16):4459-62. PubMed ID: 21873547 [TBL] [Abstract][Full Text] [Related]
32. Role of matriptase-2 (TMPRSS6) in iron metabolism. Lee P Acta Haematol; 2009; 122(2-3):87-96. PubMed ID: 19907145 [TBL] [Abstract][Full Text] [Related]
33. Induction of erythroferrone in healthy humans by micro-dose recombinant erythropoietin or high-altitude exposure. Robach P; Gammella E; Recalcati S; Girelli D; Castagna A; Roustit M; Lundby C; Lundby AK; Bouzat P; Vergès S; Séchaud G; Banco P; Uhr M; Cornu C; Sallet P; Cairo G Haematologica; 2021 Feb; 106(2):384-390. PubMed ID: 31919080 [TBL] [Abstract][Full Text] [Related]
34. Effect of Erythropoietin, Iron Deficiency and Iron Overload on Liver Matriptase-2 (TMPRSS6) Protein Content in Mice and Rats. Frýdlová J; Přikryl P; Truksa J; Falke LL; Du X; Gurieva I; Vokurka M; Krijt J PLoS One; 2016; 11(2):e0148540. PubMed ID: 26845567 [TBL] [Abstract][Full Text] [Related]
35. A critical role for murine transferrin receptor 2 in erythropoiesis during iron restriction. Wallace DF; Secondes ES; Rishi G; Ostini L; McDonald CJ; Lane SW; Vu T; Hooper JD; Velasco G; Ramsay AJ; Lopez-Otin C; Subramaniam VN Br J Haematol; 2015 Mar; 168(6):891-901. PubMed ID: 25403101 [TBL] [Abstract][Full Text] [Related]
36. Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis. Corradini E; Garuti C; Montosi G; Ventura P; Andriopoulos B; Lin HY; Pietrangelo A; Babitt JL Gastroenterology; 2009 Oct; 137(4):1489-97. PubMed ID: 19591830 [TBL] [Abstract][Full Text] [Related]
37. Matriptase-2 is essential for hepcidin repression during fetal life and postnatal development in mice to maintain iron homeostasis. Willemetz A; Lenoir A; Deschemin JC; Lopez-Otin C; Ramsay AJ; Vaulont S; Nicolas G Blood; 2014 Jul; 124(3):441-4. PubMed ID: 24904115 [TBL] [Abstract][Full Text] [Related]
38. Erythroferrone structure, function, and physiology: Iron homeostasis and beyond. Srole DN; Ganz T J Cell Physiol; 2021 Jul; 236(7):4888-4901. PubMed ID: 33372284 [TBL] [Abstract][Full Text] [Related]
39. The BMP-SMAD pathway mediates the impaired hepatic iron metabolism associated with the ERFE-A260S variant. Andolfo I; Rosato BE; Marra R; De Rosa G; Manna F; Gambale A; Iolascon A; Russo R Am J Hematol; 2019 Nov; 94(11):1227-1235. PubMed ID: 31400017 [TBL] [Abstract][Full Text] [Related]
40. Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia. Nai A; Pagani A; Mandelli G; Lidonnici MR; Silvestri L; Ferrari G; Camaschella C Blood; 2012 May; 119(21):5021-9. PubMed ID: 22490684 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]